LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 39 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 3,018 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -83.3% | 3,018 | -64.7% | 0.00% | – |
| Q1 2022 | $6,000 | -91.2% | 8,543 | -71.2% | 0.00% | – |
| Q4 2021 | $68,000 | -15.0% | 29,712 | +70.6% | 0.00% | – |
| Q3 2021 | $80,000 | -4.8% | 17,417 | -8.4% | 0.00% | – |
| Q2 2021 | $84,000 | -59.6% | 19,010 | -33.5% | 0.00% | – |
| Q1 2021 | $208,000 | +35.1% | 28,567 | +41.8% | 0.00% | – |
| Q4 2020 | $154,000 | +100.0% | 20,150 | +137.2% | 0.00% | – |
| Q3 2020 | $77,000 | +37.5% | 8,494 | +28.6% | 0.00% | – |
| Q2 2020 | $56,000 | +300.0% | 6,606 | +142.1% | 0.00% | – |
| Q1 2020 | $14,000 | -76.7% | 2,729 | -67.1% | 0.00% | – |
| Q4 2019 | $60,000 | +36.4% | 8,302 | +105.1% | 0.00% | – |
| Q3 2019 | $44,000 | -37.1% | 4,048 | -24.9% | 0.00% | – |
| Q2 2019 | $70,000 | +218.2% | 5,391 | +143.4% | 0.00% | – |
| Q1 2019 | $22,000 | +4.8% | 2,215 | +10.9% | 0.00% | – |
| Q4 2018 | $21,000 | – | 1,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
| Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
| SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
| IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
| FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
| FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |